无创正压通气治疗老年慢性阻塞性肺疾病合并重症呼吸衰竭的临床疗效观察
2020-04-21谭峻
谭峻

【摘 要】目的:探讨无创正压通气治疗老年慢性阻塞性肺疾病合并重症呼吸衰竭的临床疗效观察。方法:选取2017年6月-2018年6月我院收治的老年慢性阻塞性肺疾病合并重症呼吸衰竭患者68例,采用抽签法分为两组,对照组采取常规治疗,研究组在对照组基础上采取无创正压通气治疗。结果:治疗前动脉血气指标无明显区别(P>0.05),治疗后研究组动脉血气指标显著好于对照组(P<0.05)。结论:在治疗老年慢性阻塞性肺疾病合并呼吸衰竭的过程中,应用无创正压通气的方式进行治疗,可以使病人的临床症状进行有效缓解,同时将护理以及血气指标进行优化,减少并发症的出现,值得加大临床推广和使用。
【关键词】无创正压通气;老年慢性阻塞性肺疾病;呼吸衰竭;临床疗效观察
Abstract: objective: To investigate the clinical efficacy of noninvasive positive pressure ventilation in the treatment of elderly chronic obstructive pulmonary disease with severe respiratory failure. Methods Sixty-eight elderly patients with chronic obstructive pulmonary disease and severe respiratory failure who were admitted to our hospital from June 2017 to June 2018 were selected and divided into two groups by the lottery method. The control group received conventional treatment. The research group was based on the control group. Take non-invasive positive pressure ventilation. Results There was no significant difference in arterial blood gas index before treatment (P > 0.05). After treatment, the arterial blood gas index in the study group was significantly better than that in the control group (P<0.05). Conclusion In the treatment of elderly chronic obstructive pulmonary disease with respiratory failure, the application of non-invasive positive pressure ventilation for treatment can effectively relieve the clinical symptoms of patients, optimize the nursing and blood gas indicators, and reduce the occurrence of complications. It is worth increasing clinical promotion and use.
Keywords: non-invasive positive pressure ventilation; elderly chronic obstructive pulmonary disease; respiratory failure; clinical efficacy observation
【中图分类号】R473.5【文献标识码】A【文章编号】1672-3783(2020)04-12-014-02
老年慢性阻塞性肺疾病一种临床中较为常见的疾病,通常主要特征表现为气流受限,而且病情进展相对比较缓慢,主要临产表现为咳痰以及咳嗽和气喘等现象,当老年慢性阻塞性肺病发病之后,会使病人的肺功能出现恶化,进而导致呼吸衰竭的发生[1]。无创正压通气机可以将病人的日常生活治療进行改善,将呼吸不畅以及局部缺氧等情况进行有效调节。在此次研究中,采取无创正压通气机对老年慢性阻塞性肺疾病合并呼吸衰竭进行治疗,现进行以下报道。
1 资料与方法
1.1 一般资料
选取我院2017年6月~2018年6月收治的老年慢性阻塞性肺疾病合并呼吸衰竭患者68例,将其采用抽签法分为对照组和研究组,各34例。
患者均知情同意本研究。对照组男21例,女13例,年龄64~79岁,平均年龄(63.7±6.9)岁;研究组男18例,女16例,年龄61~78岁,平均年龄(65.3±7.2)岁。一般资料具有可比性(P>0.05),同时经过医院伦理委员会批准。
1.2 方法
1.……
